Joerg Hasford

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. pmc Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review
    Peter Bramlage
    Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany
    Cardiovasc Diabetol 8:18. 2009
  2. ncbi request reprint A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group
    J Hasford
    Institute for Medical Informatics, Biometry, and Epidemiology, University of Munich, Germany
    J Natl Cancer Inst 90:850-8. 1998
  3. ncbi request reprint The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha
    Joerg Hasford
    Universite Victor Segalen, Bordeaux, France University Hospital Groningen, Groningen, The Netherlands
    Haematologica 90:335-40. 2005
  4. doi request reprint Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed
    J Hasford
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, LMU Munchen, Marchioninistrasse 15, Munich, Germany
    J Clin Epidemiol 63:1298-304. 2010
  5. doi request reprint Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
    Joerg Hasford
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig Maximilians Universitat, Munchen, Germany
    Blood 118:686-92. 2011
  6. ncbi request reprint Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting
    J Hasford
    Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Germany
    Int J Clin Pharmacol Ther 42:415-22. 2004
  7. ncbi request reprint A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation
    Joerg Hasford
    Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Marchioninistr 15, D 81377 Munchen, Germany
    Eur J Clin Pharmacol 59:443-7. 2003
  8. ncbi request reprint A population-based European cohort study of persistence in newly diagnosed hypertensive patients
    J Hasford
    Department for Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany
    J Hum Hypertens 16:569-75. 2002
  9. ncbi request reprint Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study
    Joerg Hasford
    IBE Department of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians Universitat Munchen, Marchioninistr 15, 81377, Munich, Germany
    Eur J Clin Pharmacol 63:1055-61. 2007
  10. ncbi request reprint Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results o
    Georg Lenz
    Department of Internal Medicine III of the Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    J Clin Oncol 23:1984-92. 2005

Collaborators

Detail Information

Publications27

  1. pmc Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review
    Peter Bramlage
    Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany
    Cardiovasc Diabetol 8:18. 2009
    ..This review explores the blood pressure reduction and persistence with treatment of antihypertensive drugs and the cost consequences of poor persistence with pharmaceutical interventions in arterial hypertension...
  2. ncbi request reprint A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group
    J Hasford
    Institute for Medical Informatics, Biometry, and Epidemiology, University of Munich, Germany
    J Natl Cancer Inst 90:850-8. 1998
    ..A meta-analysis was conducted to develop a reliable prognostic scoring system for estimation of survival of patients with CML treated with interferon alfa...
  3. ncbi request reprint The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha
    Joerg Hasford
    Universite Victor Segalen, Bordeaux, France University Hospital Groningen, Groningen, The Netherlands
    Haematologica 90:335-40. 2005
    ..MCR was defined as a reduction of Philadelphia chromosome-positive bone marrow cells to <or= 35%. The New CML score discriminated three risk groups with significantly different survival probabilities...
  4. doi request reprint Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed
    J Hasford
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, LMU Munchen, Marchioninistrasse 15, Munich, Germany
    J Clin Epidemiol 63:1298-304. 2010
    ..The methodology for the critical assessment of medical interventions is well established. Regulatory agencies and institutions adhere, in principle, to the same standards. This consistency, however, is not always the case in practice...
  5. doi request reprint Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
    Joerg Hasford
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig Maximilians Universitat, Munchen, Germany
    Blood 118:686-92. 2011
    ..The score can be used to identify CML patients with significantly lower probabilities of responding to therapy and survival, thus alerting physicians to those patients who require closer observation and early intervention...
  6. ncbi request reprint Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting
    J Hasford
    Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Germany
    Int J Clin Pharmacol Ther 42:415-22. 2004
    ..This study was designed to evaluate the "real life" behavior of consumers with nonprescription access to low-dose diclofenac-K, with special focus on tolerability and the pattern of product usage...
  7. ncbi request reprint A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation
    Joerg Hasford
    Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Marchioninistr 15, D 81377 Munchen, Germany
    Eur J Clin Pharmacol 59:443-7. 2003
    ..Pharmacy-based cohort studies are feasible. This study indicates that the nicotine patch is effective and safe in an OTC setting. There is still room to improve compliance with the directions for use...
  8. ncbi request reprint A population-based European cohort study of persistence in newly diagnosed hypertensive patients
    J Hasford
    Department for Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany
    J Hum Hypertens 16:569-75. 2002
    ..Prescribing an antihypertensive agent that provides a favourable efficacy and tolerability profile may provide greater persistence with therapy and hence a higher level of blood pressure control...
  9. ncbi request reprint Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study
    Joerg Hasford
    IBE Department of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians Universitat Munchen, Marchioninistr 15, 81377, Munich, Germany
    Eur J Clin Pharmacol 63:1055-61. 2007
    ..The study described herein - which is completely independent of pharmaceutical sponsors - was undertaken to evaluate persistence with antihypertensive treatment in Germany...
  10. ncbi request reprint Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results o
    Georg Lenz
    Department of Internal Medicine III of the Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    J Clin Oncol 23:1984-92. 2005
    ....
  11. ncbi request reprint A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
    Eva Hoster
    Department of Internal Medicine III, University of Munich, Germany
    Blood 111:558-65. 2008
    ..The MIPI is the first prognostic index particularly suited for MCL patients and may serve as an important tool to facilitate risk-adapted treatment decisions in patients with advanced stage MCL...
  12. ncbi request reprint The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc
    Christian Buske
    Department of Internal Medicine III, University of Munich, Grosshadern, Marchioninistr 15, 81377 Munchen, Germany
    Blood 108:1504-8. 2006
    ..001). Our data demonstrate that the FLIPI is able to identify high-risk patients with advanced-stage FL after first-line treatment with rituximab/chemotherapy...
  13. ncbi request reprint Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Gro
    Georg Lenz
    Department of Internal Medicine III, Ludwig Maximilians University, University Hospital Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    J Clin Oncol 22:4926-33. 2004
    ....
  14. doi request reprint The association of psychosocial factors with nausea and vomiting during pregnancy
    Gertraud E Markl
    Institute for Medical Informatics, Biometry and Epidemiology, University of Munich, Germany
    J Psychosom Obstet Gynaecol 29:17-22. 2008
    ..The purpose of this study was to identify predictors for nausea and vomiting during pregnancy (NVP)...
  15. doi request reprint Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine
    Dominik Rottenkolber
    Ludwig Maximilians Universitat Munchen, Institute of Health Economics and Health Care Management and Munich Center of Health Sciences, Munich, Germany
    Basic Clin Pharmacol Toxicol 111:240-7. 2012
    ..Both blood demand and hospital procurement costs can be significantly lowered by preventing ADRs...
  16. doi request reprint Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
    Markus Pfirrmann
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie IBE, Ludwig Maximilians Universitat, Munich, Germany
    Lancet Oncol 13:207-14. 2012
    ..In a post-hoc analysis of the AML96 trial (NCT00180115), our aim was to differentiate groups of patients according to the treatments that would provide them optimum benefit...
  17. doi request reprint Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations
    Dominik Rottenkolber
    Ludwig Maximilians Universitat Munchen, Institute of Health Economics and Health Care Management and Munich Center of Health Sciences, Munich, Germany
    Pharmacoepidemiol Drug Saf 20:626-34. 2011
    ..The objective was to quantify the ADR-related economic burden (direct costs) of hospitalizations in internal medicine wards in Germany...
  18. pmc Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data
    Jurgen Stausberg
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig Maximilians Universitat Munchen, Marchioninistrase 15, D 81377 Munchen, Germany
    BMC Health Serv Res 11:134. 2011
    ..In this study, the frequency and type of drug-related admissions and hospital-acquired adverse drug events (ADE) in Germany were assessed using routinely collected hospital data...
  19. doi request reprint Costs of adverse drug events in German hospitals--a microcosting study
    Dominik Rottenkolber
    Institute of Health Economics and Health Care Management and Munich Center of Health Sciences, LMU, Munich, Germany
    Value Health 15:868-75. 2012
    ....
  20. ncbi request reprint Drug prescription in pregnancy: analysis of a large statutory sickness fund population
    Veronika Egen-Lappe
    Institute for Medical Informatics, Biometry and Epidemiology IBE, University of Munich, Marchioninistrasse 15, 81377, Munich, Germany
    Eur J Clin Pharmacol 60:659-66. 2004
    ..To examine the prescription of drugs in Germany prior to, during and after pregnancy...
  21. ncbi request reprint The impact of health care settings on survival time of patients with chronic myeloid leukemia
    Michael Lauseker
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig Maximilians Universitat, Munchen, Germany and
    Blood 123:2494-6. 2014
    ..0%). Because the impact of the health care setting on the outcome of CML patients has not been reported before, these findings need confirmation by other study groups. This trial was registered at www.clinicaltrials.gov as #NCT00055874. ..
  22. pmc Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data
    Jurgen Stausberg
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie der LMU, Muchen, Germany
    Dtsch Arztebl Int 107:23-9. 2010
    ..The aim of this study is to examine the potential usefulness of ICD-10 coded diagnoses in routine hospital data for the identification of ADE...
  23. ncbi request reprint Prescribing patterns of anti-emetic drugs during pregnancy in Germany
    Gertraud E Markl
    Institute for Medical Informatics, Biometry and Epidemiology IBE, University of Munich, Marchioninistrasse 15, Munich 81377, Germany
    Arch Gynecol Obstet 275:461-7. 2007
    ..The purpose of this study was to examine the prescribing patterns of anti-emetics for pregnant women in Germany...
  24. doi request reprint Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia
    Dorle Messerer
    Institut für Med Informationsverarbeitung, Biometrie und Epidemiologie der Universität München IBE, Marchioninistr 15, D 81377 Munchen, Germany
    Haematologica 93:826-33. 2008
    ..The German AML-Intergroup, therefore, initiated a survey on quality of life of patients with a relapse-free survival of at least 5 years after first-line treatment...
  25. ncbi request reprint Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population
    Ute Amann
    Institute for Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany
    Pharmacoepidemiol Drug Saf 15:327-37. 2006
    ..Antibiotics are frequently prescribed drugs in pregnancy. The purpose of the study was to analyse the use, the potential risks and the determinants of systemic antibiotic prescriptions during pregnancy...
  26. ncbi request reprint Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia
    Markus Pfirrmann
    Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie IBE, Ludwig Maximilians Universitat, Marchioninistrase 15, 81377, Munich, Germany
    J Cancer Res Clin Oncol 140:1367-81. 2014
    ..Prior to the decision on a combined analysis of both studies, reasons for this discrepancy had to be investigated...
  27. ncbi request reprint Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European
    Martin Dreyling
    Department of Internal Medicine III, Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    Blood 105:2677-84. 2005
    ..18). Early consolidation by myeloablative radiochemotherapy followed by ASCT is feasible and results in a significant prolongation of PFS in advanced-stage MCL. Longer follow-up is needed to determine the effect on OS...